Adline Chem Lab Reports Q3FY26 Loss of ₹6.46 Lakhs, Appoints New Chairman & MD

2 min read     Updated on 10 Feb 2026, 06:57 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Adline Chem Lab Limited announced Q3FY26 financial results showing a net loss of ₹6.46 lakhs, improved from ₹12.26 lakhs loss in Q3FY25, with zero revenue from operations. The company also appointed Mr. Vrushank Balkrushna Patel as Chairman and Managing Director for five years, subject to shareholder approval.

32275667

*this image is generated using AI for illustrative purposes only.

Adline Chem Lab Limited has announced its unaudited standalone financial results for the quarter ended December 31, 2025, alongside the appointment of Mr. Vrushank Balkrushna Patel as Chairman and Managing Director. The board of directors approved both developments during their meeting held on February 10, 2026.

Q3FY26 Financial Performance

The company reported a net loss of ₹6.46 lakhs for the quarter ended December 31, 2025, compared to a loss of ₹12.26 lakhs in the corresponding quarter of the previous year. The company recorded zero revenue from operations during the quarter.

Financial Metric: Q3FY26 Q3FY25 Nine Months FY26 Nine Months FY25
Revenue from Operations: - - - -
Other Income: - - - -
Total Expenses: ₹7.24 lakhs ₹13.14 lakhs ₹21.13 lakhs ₹36.74 lakhs
Net Loss: ₹6.46 lakhs ₹12.26 lakhs ₹18.85 lakhs ₹34.16 lakhs
Earnings Per Share: (₹0.01) (₹0.02) (₹0.03) (₹0.06)

For the nine-month period ended December 31, 2025, the company's net loss stood at ₹18.85 lakhs, showing improvement from ₹34.16 lakhs loss in the corresponding period of the previous year.

Expense Breakdown

The company's total expenses for Q3FY26 decreased to ₹7.24 lakhs from ₹13.14 lakhs in Q3FY25. The major expense components included:

Expense Category: Q3FY26 Q3FY25
Employee Benefits: ₹1.01 lakhs ₹4.72 lakhs
Finance Costs: ₹4.24 lakhs ₹3.48 lakhs
Other Expenses: ₹1.98 lakhs ₹4.95 lakhs

Leadership Appointment

The board approved the appointment of Mr. Vrushank Balkrushna Patel as Chairman and Managing Director for a period of five years, effective February 10, 2026. This appointment follows the resignation of Mr. Sarang Pathak from his directorship position and is subject to shareholder approval.

Appointment Details: Information
Appointee: Mr. Vrushank Balkrushna Patel
DIN: 05310613
Position: Chairman and Managing Director
Term Duration: Five years
Effective Date: February 10, 2026

Mr. Patel is an undergraduate who studied till the 4th year of Civil Engineering from South Gujarat University. He has been actively involved in Green Energy Generation, Real Estate Business, and Import & Trading of Natural Resources since 2013.

Regulatory Compliance

The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) and reviewed by the company's statutory auditors, Jain Kedia & Sharma Chartered Accountants. The audit committee recommended the results for adoption, which were subsequently approved by the board of directors. The company maintains a paid-up equity share capital of ₹585.00 lakhs with shares having a face value of ₹10 each.

Historical Stock Returns for Adline Chem Lab

1 Day5 Days1 Month6 Months1 Year5 Years
-4.99%-4.99%+3.10%-21.92%-9.20%+71.21%

Adline Chem Lab Updates CFO Resignation Details Following Board Changes

1 min read     Updated on 13 Nov 2025, 01:30 AM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Adline Chem Lab Limited has submitted supplementary information regarding CFO Kuldip Ashokkumar Parekh's resignation due to better career opportunities, effective June 13, 2025. This follows the company's recent board restructuring in November 2025, where Vrushank Patel was appointed as Chairman replacing Sarang Bharatbhai Pathak. The company reported a loss before tax of ₹13.89 lakhs for the half-year ended September 30, 2025.

24523218

*this image is generated using AI for illustrative purposes only.

Adline Chem Lab Limited has provided additional details regarding its Chief Financial Officer resignation in a fresh corporate announcement dated December 30, 2025. This follows the company's earlier significant board restructuring and financial results disclosure from November 2025.

CFO Resignation Details

The company has submitted supplementary information regarding the resignation of Mr. Kuldip Ashokkumar Parekh from his position as Chief Financial Officer. The resignation details are as follows:

Parameter: Details
Name: Kuldip Ashokkumar Parekh
Position: Chief Financial Officer (KMP)
Resignation Date: June 13, 2025
Reason: Other pre-occupations and better career opportunities

This announcement serves as additional information to the company's earlier corporate announcement dated June 13, 2025, regarding the outcome of the board meeting held on the same date. The board had duly accepted Mr. Parekh's resignation during that meeting.

Previous Leadership Changes

The company has undergone significant management changes in recent months. In November 2025, Adline Chem Lab announced major shifts in its top management:

  • Sarang Bharatbhai Pathak resigned from his position as Executive Director-Chairman (Managing Director)
  • Hemant Amrish Parikh stepped down as Non-Executive Promoter Director
  • Vrushank Patel was appointed as the new Chairman of the Board

Board Committee Restructuring

Following the leadership changes, the company restructured its board committees with new compositions for the Audit Committee, Nomination Remuneration and Compensation Committee, and Stakeholders Relationship Committee, all featuring appropriate independent director representation.

Recent Financial Performance

The company's latest financial results for the quarter and half-year ended September 30, 2025, showed:

Financial Metric: Amount (₹ in lakhs)
Cash and Cash Equivalents: 7.36
Loss Before Tax (Half-year): 13.89

Regulatory Compliance

The fresh corporate announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The document was digitally signed by Vrushank B. Patel, Director (DIN: 05310613), ensuring proper regulatory compliance and transparency for stakeholders.

Historical Stock Returns for Adline Chem Lab

1 Day5 Days1 Month6 Months1 Year5 Years
-4.99%-4.99%+3.10%-21.92%-9.20%+71.21%
1 Year Returns:-9.20%